EDIL3 and arthritic joint disease: DEL-1 has been reported to promote homeostasis and improve the outcome of disease in adult experimental models of periodontal inflammation, arthritis, experimental autoimmune encephalomyelitis and LPS-induced adrenal gland inflammation8,14,20,21,40,41.